Form 4: Hims & Hers CFO Exercises, Sells Shares

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and immediately sold an equal number of Class A Common Stock shares under a pre-arranged 10b5-1 trading plan.

Summary

• Chief Financial Officer Oluyemi Okupe exercised 5,262 stock options for Class A Common Stock at an exercise price of $5.01 per share.
• Concurrently, Okupe sold 5,262 shares of Class A Common Stock at an average weighted price of $26.4363 per share, with individual sales ranging from $26.35 to $26.56.
• These transactions occurred on February 3, 2026, and were executed pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025.
• Following these transactions, Okupe directly holds 91,617 shares of Class A Common Stock and indirectly holds 7,853 shares through the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
• Okupe also retains 144,051 unexercised stock options with an exercise price of $5.01, which vest over a 4-year period starting March 24, 2022, and expire on February 23, 2032.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an executive sale can sometimes be perceived negatively, its execution under a pre-arranged 10b5-1 plan mitigates concerns about its implications for the company's immediate prospects.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned, non-discretionary sale rather than a reaction to new material non-public information.
• The significant difference between the exercise price of $5.01 and the sale price of $26.4363 demonstrates a substantial gain for the CFO, reflecting positive past stock performance for Hims & Hers Health, Inc.

Negatives

• An executive selling shares, even under a 10b5-1 plan, reduces their direct equity stake in the company, which could be perceived as a slight reduction in direct alignment with shareholder interests.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions, especially those executed under pre-arranged 10b5-1 plans, are common across all industries as a mechanism for executives to manage personal finances and diversify holdings without implying a change in their outlook on the company's future performance. This transaction is typical for a CFO managing vested equity.

Stakeholder Impact

• Shareholders: The sale of shares by a CFO, even under a 10b5-1 plan, slightly reduces the direct alignment of the executive's personal wealth with the company's stock performance, though the remaining holdings are substantial.

Key Dates

Recommendation

The transaction is a routine insider sale executed under a pre-arranged 10b5-1 plan, which typically does not signal a change in the company's fundamentals or future outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, CFO, Oluyemi Okupe, 10b5-1 Plan, Beneficial Ownership